신풍제약

019170KOSPI의약품 제조업

44.9 / 100

Reference Date: 2026-04-13

Financial Score15.0 / 40

News Sentiment11.9 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly down 4.2% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Shinpoong Pharmaceutical is enhancing its competitiveness in the highly competitive domestic pharmaceutical market through global new drug development, improved generics, and first-generic launches, while focusing investments on high-profit products to improve profitability. Although sales increased by approximately 10.42% compared to the previous period, the company still recorded an operating loss due to ongoing R&D expenses.

Number of Employees

792people

Average Salary

77.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

66.57Industry Average 14.800.0Point

4.5x industry avg (risky)

PBR

2.06Industry Average 1.041.0Point

2.0x industry avg (risky)

ROE

3.17Industry Average 4.422.5Point

Below industry avg

Debt Ratio

5.48Industry Average 11.986.5Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲8.3% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲113.3% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -7.2% (improving, 3yr)

Detailed News Sentiment

9 totalPositive 1Neutral 2Negative 1Average Sentiment Score 45

Neutral
“31일에만 667곳 몰렸다”…상장사 ‘슈퍼 주총데이’ 보니
3월 다섯째 주에 많은 상장사들이 정기 주주총회를 개최한다는 내용으로, 신풍제약도 주총을 개최한다는 언급이 있습니다.
Negative
베트남 당국, 신풍제약 진통·소염제 '아클론' 전량 회수 지시
신풍제약의 진통·소염제 '아클론'이 베트남 당국으로부터 품질 기준 미달로 전국 회수 조치를 받아 제품 신뢰도에 부정적인 영향을 미치고 있습니다.
Positive
'코로나 특수' 그늘 벗어난 신약·진단기업…체질개선 앞세워 반등
신풍제약은 코로나19 엔데믹 이후 매출 구조 재편, 연구개발비 감소, 신성장 동력 사업 매출 성장을 통해 지난해 흑자전환에 성공하며 체질 개선에 성공했다.

Detailed Momentum

52-week position3.0Point

52w lower range (30%)

Current 10,540Won52-week high 17,83052-week low 7,390

1-month return2.0Point

1m -4.18% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-30
Neutral정기주주총회결과2026-03-30
Neutral사업보고서 (2025.12)2026-03-20
Neutral감사보고서제출2026-03-19